RNS REACH
AIM: FIPP
9 May 2017
Frontier IP Group Plc
("Frontier IP" or the "Group")
Three Group nominations for Royal Society of Chemistry awards
Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that two of its portfolio companies, Alusid Limited ("Alusid") and Exscientia Limited ("Exscientia") have received nominations for a total of three awards at the Royal Society of Chemistry's forthcoming Chemistry World flagship event in June.
Alusid has been shortlisted for the Emerging Technologies competition for its multi-award winning Architectural surfacing Eco-materials, made from fused recycled glass and ceramics using a low energy process, designed as an adaptable alternative to natural stone. Alusid aims to be a leader in the supply of premium engineered sustainable architectural materials and remains at the forefront of this growing sector through continuous research and development.
Exscientia is at the forefront of small molecule drug discovery. It applies a wealth of AI techniques to automate drug design in a manner that surpasses conventional human endeavour. In just three years Exscientia has already grown a portfolio of global collaborations that include Sanofi, Sumitomo Dainippon and Sunovion. Exscientia sees two of its staff shortlisted to the final three, Andrew Hopkins, as Chemistry World Entrepreneur of the Year and Jérémy Besnard for the Rising Star in Industry Award.
Neil Crabb, CEO of Frontier IP, commented "It is pleasing to see both companies continuing to garner recognition for the excellence of their technologies and people as they drive commercial success in their respective marketplaces".
ENDS
For further information:
Frontier IP Group Plc |
T: 0131 240 1251 |
Neil Crabb, Chief Executive Company website: www.frontierip.co.uk |
|
|
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) |
T: 0131 220 6939 |
Neil McDonald / Beth McKiernan |
|
|
|
Peterhouse Corporate Finance Limited (Joint Broker) |
T: 020 7469 0935 |
Lucy Williams |
|
|
|
Kreab (Financial PR) |
T: 020 7074 1800 |
Robert Speed / Matthew Jervois |
|
Notes to Editor:
About Frontier IP Group plc
www.frontierip.co.uk.
Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.
About Alusid
www.alusid.co.uk
ALUSID - a university spinoff company - was born from a research project led by Professor David Binns and Dr Alasdair Bremner, at the University of Central Lancashire. Alusid aims to be a leader in the supply of premium engineered sustainable architectural materials and remains at the forefront of this growing sector through continuous research and development.
About Exscientia
www.exscientia.co.uk
Exscientia is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design. By fusing the power of AI with the discovery experience of seasoned drug hunters, it is the first company to automate drug design, surpassing conventional approaches. Its innovative platform enables breakthrough productivity gains with new approaches to improve drug efficacy. It is delivering a pipeline of efficacious, bispecific small molecules, as well as highly selective single target candidates, for multiple indications.
